Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Baxter opens Advate facility in Singapore

Follows EU approval for haemophilia A drug plant

MS market set to grow 4% annually

Predictedto reach $20bn by 2023 partly due to Plegridy and ocrelizumab launches

- PMLiVE

Roche blasts UK’s ‘broken’ HTA system as Kadcyla rejected

But NICE says it is 'very disappointed' with the company's pricing policy

- PMLiVE

emotive continues to grow

London digital agency appoints Aaron Joshua Barroso digital marketing manager

- PMLiVE

Has the biological revolution in rheumatoid arthritis peaked?

In the short term the focus looks set to be on personalised use of existing therapies

- PMLiVE

Janssen looks to NASCAR for atrial fibrillation awareness

Company's MyAFibStory.com 400 kicks off the NASCAR Sprint Cup series

- PMLiVE

Determining value to withstand all tests

The late arrival of an early role for communications

Sanofi reception

Sanofi asks Emcure to sell its cancer drugs in India

Will hand over marketing of Taxotere, Jevtana, Fludara and Fasturtec

India has big plans for healthcare and pharma

And the European industry is keen to engage with the new Modi government

- PMLiVE

US talks tough on ‘unpatriotic’ tax inversion deals

Treasury looks to 'meaningfully reduce' tax benefits of such manoeuvres

- PMLiVE

AbbVie begins ‘first-of-its-kind’ hep C charity pilot

Will work with Addaction Cornwall and The Hepatitis C Trust

- PMLiVE

FDA approves antibacterial skin drug Orbactiv

US regulator authorises Medicines Company's treatment for ABSSSI

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links